Knockdown of ZFX inhibits gastric cancer cell growth in vitro and in vivo via downregulating the ERK-MAPK pathway

Cancer Letters

Volumn 337, Issue 2, 2013, Pages 293-300

  Wu, Shuai ^a,b,c   Lao, Xin Yuan ^d   Sun, Tian Tian ^a,b,c   Ren, Lin Lin ^a,b,c   Kong, Xuan ^a,b,c   Wang, Ji Lin ^a,b,c   Wang, Ying Chao ^a,b,c   Du, Wan ^a,b,c   Yu, Ya Nan ^a,b,c   Weng, Yu Rong ^a,b,c   Hong, Jie ^a,b,c   Fang, Jing Yuan ^a,b,c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c School of Medicine   (China)

^d Holly Lab Shanghai   (China)

Author keywords

ERK MAPK; Gastric cancer (GC); Zinc finger protein X linked (ZFX)

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN X;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENICITY; CELL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; S PHASE CELL CYCLE CHECKPOINT; STOMACH CANCER; UPREGULATION;

ERK-MAPK; GASTRIC CANCER (GC); ZINC FINGER PROTEIN X-LINKED (ZFX);

ANIMALS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE KNOCKDOWN TECHNIQUES; GENETIC THERAPY; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, NUDE; MIDDLE AGED; RNA INTERFERENCE; STOMACH NEOPLASMS; TIME FACTORS; TRANSFECTION; TUMOR BURDEN;

EID: 84880514097     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.04.003     Document Type: Article

References (35)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
2. You W.C., Li J.Y., Zhang L., Jin M.L., Chang Y.S., Ma J.L., Pan K.F. Etiology and prevention of gastric cancer: a population study in a high risk area of China. Chin. J. Dig. Dis. 2005, 6:149-154.
3. Schneider-Gadicke A., Beer-Romero P., Brown L.G., Mardon G., Luoh S.W., Page D.C. Putative transcription activator with alternative isoforms encoded by human ZFX gene. Nature 1989, 342:708-711.
4. Galan-Caridad J.M., Harel S., Arenzana T.L., Hou Z.E., Doetsch F.K., Mirny L.A., Reizis B. Zfx controls the self-renewal of embryonic and hematopoietic stem cells. Cell 2007, 129:345-357.
5. Cellot S., Sauvageau G. Zfx: at the crossroads of survival and self-renewal. Cell 2007, 129:239-241.
6. Harel S., Tu E.Y., Weisberg S., Esquilin M., Chambers S.M., Liu B., Carson C.T., Studer L., Reizis B., Tomishima M.J. ZFX controls the self-renewal of human embryonic stem cells. PLoS One 2012, 7:e42302.
7. Ben-Porath I., Thomson M.W., Carey V.J., Ge R., Bell G.W., Regev A., Weinberg R.A. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 2008, 40:499-507.
8. Chen X., Xu H., Yuan P., Fang F., Huss M., Vega V.B., Wong E., Orlov Y.L., Zhang W., Jiang J., Loh Y.H., Yeo H.C., Yeo Z.X., Narang V., Govindarajan K.R., Leong B., Shahab A., Ruan Y., Bourque G., Sung W.K., Clarke N.D., Wei C.L., Ng H.H. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008, 133:1106-1117.
9. Hu G., Kim J., Xu Q., Leng Y., Orkin S.H., Elledge S.J. A genome-wide RNAi screen identifies a new transcriptional module required for self-renewal. Genes Dev. 2009, 23:837-848.
10. Zhou Y., Su Z., Huang Y., Sun T., Chen S., Wu T., Chen G., Xie X., Li B., Du Z. The Zfx gene is expressed in human gliomas and is important in the proliferation and apoptosis of the human malignant glioma cell line U251. J. Exp. Clin. Cancer Res. 2011, 30:114.
11. Fang J., Yu Z., Lian M., Ma H., Tai J., Zhang L., Han D. Knockdown of zinc finger protein, X-linked (ZFX) inhibits cell proliferation and induces apoptosis in human laryngeal squamous cell carcinoma. Mol. Cell Biochem. 2012, 360:301-307.
12. Jiang H., Zhang L., Liu J., Chen Z., Na R., Ding G., Zhang H., Ding Q. Knockdown of zinc finger protein X-linked inhibits prostate cancer cell proliferation and induces apoptosis by activating caspase-3 and caspase-9. Cancer Gene Ther. 2012, 19:684-689.
13. Tricoli J.V., Bracken R.B. ZFY gene expression and retention in human prostate adenocarcinoma. Genes Chromosomes Cancer 1993, 6:65-72.
14. Tang D.J., Dong S.S., Ma N.F., Xie D., Chen L., Fu L., Lau S.H., Li Y., Guan X.Y. Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma. Hepatology 2010, 51:1255-1263.
15. Lu R., Wang X., Chen Z.F., Sun D.F., Tian X.Q., Fang J.Y. Inhibition of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway decreases DNA methylation in colon cancer cells. J. Biol. Chem. 2007, 282:12249-12259.
16. Wang M., Gartel A.L. The suppression of FOXM1 and its targets in breast cancer xenograft tumors by siRNA. Oncotarget 2011, 2:1218-1226.
17. Wei M.C., Zong W.X., Cheng E.H., Lindsten T., Panoutsakopoulou V., Ross A.J., Roth K.A., MacGregor G.R., Thompson C.B., Korsmeyer S.J. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001, 292:727-730.
18. Jurgensmeier J.M., Xie Z., Deveraux Q., Ellerby L., Bredesen D., Reed J.C. Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl. Acad. Sci. USA 1998, 95:4997-5002.
19. Deng X., Xiao L., Lang W., Gao F., Ruvolo P., May W.S. Novel role for JNK as a stress-activated Bcl2 kinase. J. Biol. Chem. 2001, 276:23681-23688.
20. Murphy K.M., Ranganathan V., Farnsworth M.L., Kavallaris M., Lock R.B. Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells. Cell Death Differ. 2000, 7:102-111.
21. Ye X., Nalepa G., Welcker M., Kessler B.M., Spooner E., Qin J., Elledge S.J., Clurman B.E., Harper J.W. Recognition of phosphodegron motifs in human cyclin E by the SCF(Fbw7) ubiquitin ligase. J. Biol. Chem. 2004, 279:50110-50119.
22. Lukas J., Bartkova J., Bartek J. Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint. Mol. Cell Biol. 1996, 16:6917-6925.
23. Sherr C.J. Cancer cell cycles. Science 1996, 274:1672-1677.
24. Pagano M., Pepperkok R., Verde F., Ansorge W., Draetta G. Cyclin A is required at two points in the human cell cycle. EMBO J. 1992, 11:961-971.
25. Roberts P.J., Der C.J. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 2007, 26:3291-3310.
26. Hong S.K., Yoon S., Moelling C., Arthan D., Park J.I. Noncatalytic function of ERK1/2 can promote Raf/MEK/ERK-mediated growth arrest signaling. J. Biol. Chem. 2009, 284:33006-33018.
27. Akiyoshi S., Fukagawa T., Ueo H., Ishibashi M., Takahashi Y., Fabbri M., Sasako M., Maehara Y., Mimori K., Mori M. Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases. Br. J. Cancer 2012, 107:1345-1353.
28. Nikpour P., Emadi-Baygi M., Mohammad-Hashem F., Maracy M.R., Haghjooy-Javanmard S. Differential expression of ZFX gene in gastric cancer. J. Biosci. 2012, 37:85-90.
29. Correa P., Haenszel W., Cuello C., Tannenbaum S., Archer M. A model for gastric cancer epidemiology. Lancet 1975, 2:58-60.
30. Fu L., Chen L., Yang J., Ye T., Chen Y., Fang J. HIF-1alpha-induced histone demethylase JMJD2B contributes to the malignant phenotype of colorectal cancer cells via an epigenetic mechanism. Carcinogenesis 2012, 33:1664-1673.
31. Yan L., Gu H., Li J., Xu M., Liu T., Shen Y., Chen B., Zhang G. RKIP and 14-3-3epsilon exert an opposite effect on human gastric cancer cells SGC7901 by regulating the ERK/MAPK pathway differently. Dig. Dis. Sci. 2012.
32. De Luca A., Maiello M.R., D'Alessio A., Pergameno M., Normanno N. The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches. Expert Opin. Ther. Targets 2012, 16(Suppl. 2):S17-S27.
33. Levidou G., Saetta A.A., Gigelou F., Karlou M., Papanastasiou P., Stamatelli A., Kavantzas N., Michalopoulos N.V., Agrogiannis G., Patsouris E., Korkolopoulou P. ERK/pERK expression and B-raf mutations in colon adenocarcinomas: correlation with clinicopathological characteristics. World J. Surg. Oncol. 2012, 10:47.
34. Santarpia L., Lippman S.M., El-Naggar A.K. Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert Opin. Ther. Targets 2012, 16:103-119.
35. Fang J.Y., Richardson B.C. The MAPK signalling pathways and colorectal cancer. Lancet Oncol. 2005, 6:322-327.